5 Biggest Pharmaceutical Companies in the World

4. Eli Lilly and Company (NYSE: LLY)

Market Capitalization as of September 11, 2021: $229.1 billion

Market Capitalization as of September 02, 2022: $286.3 billion

The core values that have been established by Eli Lilly and Company (NYSE: LLY) make a huge difference in making this company rule over all around the world in terms of medicines and health care products. The products of Eli Lilly and Company (NYSE: LLY) are sold in over 124 countries around the globe. The company is most popular for being the largest producer of psychiatric medications such as Zyprexa, Prozac, and Dolophine. People at Eli Lilly and Company (NYSE: LLY) are continuously struggling to discover and make new ways through which they can promote a better living environment worldwide.

In the Q2 2021 investor letter of DEVON Equity Management, the fund mentioned Eli Lilly and Company (NYSE: LLY). Here is what the fund said:

“In one of the most controversial moves in its long history, the US FDA approved Biogen’s (BIIB US) Alzheimer’s drug Aducanamab for commercial usage. The background is complicated and beyond the scope of this letter, but the controversy centres on both the interpretation of clinical trial data and the efficacy of the drug itself. The ultimate surprise came in June, when the FDA approved Aducanamab for commercial use with generous labelling (until at least 2030) in direct contradiction to the recommendation of the FDA’s own Advisory Committee of experts (AdCom), who in December 2020 voted against approval by 10 to 0 (with one abstention).

The decision caused a storm of criticism from clinicians and triggered a wave of resignations from members of the AdCom who had issued the original judgement (though ‘advisory’, the views of these expert panels typically carry enormous weight with the FDA)…” (Click here to see the full text)